Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |